Table 2 Distribution of normal, non-stenotic, significantly stenotic, and non-evaluable segments among both techniques
Segment evaluation | CCTA | CAG | |||
|---|---|---|---|---|---|
Number | Percentage (%) | Number | Percentage (%) | ||
No significant stenosis | Normal segments | 513 | 67.1% | 529 | 69.2% |
< 50 lesion | 226 | 29.6% | 168 | 22% | |
Significant stenosis | ≥ 50% lesion | 23 | 3% | 21 | 2.7% |
Totally occluded | 2 | 0.3% | 3 | 0.4% | |
Unevaluable | 0 | 0% | 43 | 5.7% | |
Total | 764 | 100% | 764 | 100% | |